Viewing data from:

CLINDAMYCIN PALMITATE HYDROCHLORIDE

ANDA

CLINDAMYCIN PALMITATE HYDROCHLORIDE | A203063 | EXTROVIS AG

1 strength0 unique patents0 unique exclusivities

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

PHARMACIA AND UPJOHN CO LLCCLINDAMYCIN PALMITATE HYDROCHLORIDE USP KALAMAZOO

DMF 134121998

APITORIA PHARMA PRIVATE LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE USP (NON-STERILE DRUG SUBSTANCE)

DMF 234362009

CHONGQING BIOCARE PHARMACEUTICAL LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE USP, NON-STERILE, BULK DRUG

DMF 239742010

SCI PHARMTECH INCCLINDAMYCIN PALMITATE HYDROCHLORIDE

DMF 249172011

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE (PROCESS B)

DMF 272762013

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE

DMF 218962008

LUPIN LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE USP

DMF 231152009

MYLAN LABORATORIES LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE USP

DMF 240182010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 75MG BASE/5ML

0 patents0 exclusivities▴

FOR SOLUTION;ORAL | Approved: May 25, 2016

No patent or exclusivity listings for this strength.